iZafe Group (M02) Stock Overview

A medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. More details

M02 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Makes less than USD$1m in revenue (SEK7M)

Shareholders have been substantially diluted in the past year

Has less than 1 year of cash runway

Volatile share price over the past 3 months compared to the German market

+ 1 more risk

M02 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW479,582 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

479,582 investors already sharing narratives

View all narratives

iZafe Group AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for iZafe Group
Historical stock prices
Current Share Price	SEK 0.031
52 Week High	SEK 0.04
52 Week Low	SEK 0.02
Beta	-0.010
1 Month Change	-14.21%
3 Month Change	-12.29%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-21.50%

Recent updates

Shareholder Returns

	M02	DE Healthcare Services	DE Market
7D	-0.6%	-0.6%	0.1%
1Y	n/a	9.5%	-0.5%

Return vs Industry: Insufficient data to determine how M02 performed against the German Healthcare Services industry.

Return vs Market: Insufficient data to determine how M02 performed against the German Market.

Price Volatility

Is M02's price volatile compared to industry and market?
M02 volatility
M02 Average Weekly Movement	9.6%
Healthcare Services Industry Average Movement	5.1%
Market Average Movement	5.3%
10% most volatile stocks in DE Market	12.7%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: M02's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine M02's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2008	11	Anders Segerstrom	www.izafe.se

iZafe Group AB (publ), a medical technology company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated medication dispenser that handles medication pouches, smart pillboxes, facilitates and enables independent medication, and reminds and alerts in the scheduled doses. It also offers Pilloxa, a platform that provides real-time insights and improved data quality to empower and motivate patients.

iZafe Group AB (publ) Fundamentals Summary

How do iZafe Group's earnings and revenue compare to its market cap?
M02 fundamental statistics
Market cap	€12.49m
Earnings (TTM)	-€1.75m
Revenue (TTM)	€640.84k

19.5x

P/S Ratio

-7.1x

P/E Ratio

Is M02 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
M02 income statement (TTM)
Revenue	SEK 7.09m
Cost of Revenue	SEK 3.31m
Gross Profit	SEK 3.78m
Other Expenses	SEK 23.20m
Earnings	-SEK 19.42m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

Sep 01, 2026

Earnings per share (EPS)	-0.045
Gross Margin	53.27%
Net Profit Margin	-273.83%
Debt/Equity Ratio	0%

How did M02 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/22 22:18
End of Day Share Price	2026/07/22 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

iZafe Group AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jesper Birch-Jensen	ABG Sundal Collier Sponsored

iZafe Group AB (publ)DB:M02 Stock Report